Atlas Trials

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Clinical trial NCT03688971 · UNKNOWN

Trial details

NCT number
NCT03688971
Sponsor
Maruho Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Seborrheic Dermatitis
Start date
2018-10-22
Primary completion
2019-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.